Chemo-inducible gene therapy

Anticancer Drugs. 2005 Nov;16(10):1053-8. doi: 10.1097/00001813-200511000-00003.

Abstract

Chemo-inducible cancer gene therapy is a potential new treatment for solid tumors that may in part enhance the anti-tumor effects of chemotherapy while minimizing toxicity. This approach combines viral vectors expressing cytotoxic transgenes that can be transcriptionally activated by DNA-damaging agents. The development of chemo-inducible gene therapy has numerous implications for the treatment of both localized and metastatic disease in patients with solid tumors.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • DNA / drug effects
  • DNA Damage
  • Early Growth Response Protein 1 / genetics
  • Genes, MDR / genetics
  • Genetic Therapy / methods*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Promoter Regions, Genetic / genetics
  • Transcription, Genetic / drug effects*
  • Transcription, Genetic / radiation effects
  • Tumor Necrosis Factors / genetics

Substances

  • Antineoplastic Agents
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Tumor Necrosis Factors
  • DNA